Compare CDNA & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | CENX |
|---|---|---|
| Founded | 1998 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Aluminum |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.3B |
| IPO Year | 2007 | 2004 |
| Metric | CDNA | CENX |
|---|---|---|
| Price | $78.26 | $34.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $94.43 | $55.80 |
| AVG Volume (30 Days) | 1.3M | ★ 2.1M |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.45 | ★ 8.50 |
| Revenue | $48,324,000.00 | ★ $1,893,200,000.00 |
| Revenue This Year | $38.18 | $31.68 |
| Revenue Next Year | $8.98 | $24.27 |
| P/E Ratio | $32.57 | ★ $4.19 |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $15.15 | $25.40 |
| 52 Week High | $90.87 | $70.43 |
| Indicator | CDNA | CENX |
|---|---|---|
| Relative Strength Index (RSI) | 55.14 | 47.22 |
| Support Level | $17.15 | $30.25 |
| Resistance Level | $90.87 | $35.39 |
| Average True Range (ATR) | 5.25 | 1.96 |
| MACD | -0.64 | 0.49 |
| Stochastic Oscillator | 43.11 | 58.89 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. The company also owns a carbon anode production facility in the Netherlands.